The Centers for Medicare & Medicaid Services (CMS) EQRS submission deadlines for the calendar year (CY) 2023 reporting months are listed below.

DID YOU KNOW THAT CMS RECENTLY UPDATED QIP TO INCLUDE A MEASURE OF VACCINATION RATES AMONG DIALYSIS HEALTHCARE PERSONNEL?
This is a 2-part measure:

The Centers for Medicare & Medicaid Services (CMS) will release the Payment Year (PY) 2023 End-Stage Renal Disease Quality Incentive Program (ESRD QIP) Final Performance Score Reports (PSRs) and Performance Score Certificates (PSCs).

HC3 is closely tracking hacktivist groups which have previously affected a wide range of countries and industries, including the United States Healthcare and Public Health (HPH) sector.

Once the emergency ends, Medicare beneficiaries generally will face out-of-pocket costs for at-home testing and all treatment. However, vaccines will continue to be covered at no cost, as will testing ordered by a health care provider.

Medtronic is recalling the Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters due to a potential catheter hub defect that may cause leaks across the catheter’s tubes.

Exela Pharma Sciences, LLC, (Exela) is expanding their recall, adding fourteen (14) lots to the ongoing voluntary recall of forty-nine (49) lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton.

The FDA is investigating the risk of severe hypocalcemia with serious outcomes, including hospitalization and death, in patients with advanced kidney disease on dialysis treated with the osteoporosis medicine Prolia (denosumab).

Dialysis Providers: The Centers for Medicare & Medicaid Services (CMS) End Stage Renal Disease Quality Incentive Program (ESRD QIP) reminds you that the payment year (PY) 2023 ESRD QIP preview period o

Pages